EU Medicines Agency Says Benefits of AstraZeneca Vaccine Still Outweigh Risks
April 07 2021 - 10:45AM
Dow Jones News
By Dan Michaels
BRUSSELS--The European Union's health agency said it had found
possible links between AstraZeneca PLC's Covid-19 vaccine and rare
blood clots but said the shot's benefits continue to outweigh
potential risks. The European Medicines Agency found no specific
risk factors linking the vaccine to the clots.
Write to Dan Michaels at dan.michaels@wsj.com
(END) Dow Jones Newswires
April 07, 2021 10:30 ET (14:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
